KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Revenue (2016 - 2025)

Repligen (RGEN) has disclosed Revenue for 16 consecutive years, with $197.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 18.12% to $197.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $738.3 million, a 16.36% increase, with the full-year FY2025 number at $738.3 million, up 16.36% from a year prior.
  • Revenue was $197.9 million for Q4 2025 at Repligen, up from $188.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $207.6 million in Q2 2022 to a low of $141.2 million in Q3 2023.
  • A 5-year average of $173.9 million and a median of $168.4 million in 2024 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 89.47% in 2021, then decreased 29.66% in 2023.
  • Repligen's Revenue stood at $186.5 million in 2021, then increased by 0.13% to $186.8 million in 2022, then fell by 10.78% to $166.6 million in 2023, then rose by 0.56% to $167.5 million in 2024, then increased by 18.12% to $197.9 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Revenue are $197.9 million (Q4 2025), $188.8 million (Q3 2025), and $182.4 million (Q2 2025).